China Reform Health Management and Services Group Co Ltd (000503) - Net Assets
Based on the latest financial reports, China Reform Health Management and Services Group Co Ltd (000503) has net assets worth CN¥1.27 Billion CNY (≈ $185.41 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.01 Billion ≈ $294.40 Million USD) and total liabilities (CN¥744.82 Million ≈ $108.99 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 000503 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.27 Billion |
| % of Total Assets | 62.98% |
| Annual Growth Rate | 8.53% |
| 5-Year Change | 45.78% |
| 10-Year Change | 1.86% |
| Growth Volatility | 47.23 |
China Reform Health Management and Services Group Co Ltd - Net Assets Trend (1992–2024)
This chart illustrates how China Reform Health Management and Services Group Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore China Reform Health Management and Servi balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for China Reform Health Management and Services Group Co Ltd (1992–2024)
The table below shows the annual net assets of China Reform Health Management and Services Group Co Ltd from 1992 to 2024. For live valuation and market cap data, see 000503 market cap overview.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.41 Billion ≈ $205.68 Million |
-1.11% |
| 2023-12-31 | CN¥1.42 Billion ≈ $207.99 Million |
+99.35% |
| 2022-12-31 | CN¥712.99 Million ≈ $104.33 Million |
-9.43% |
| 2021-12-31 | CN¥787.23 Million ≈ $115.20 Million |
-18.36% |
| 2020-12-31 | CN¥964.22 Million ≈ $141.10 Million |
-21.45% |
| 2019-12-31 | CN¥1.23 Billion ≈ $179.62 Million |
+0.81% |
| 2018-12-31 | CN¥1.22 Billion ≈ $178.18 Million |
-12.58% |
| 2017-12-31 | CN¥1.39 Billion ≈ $203.83 Million |
-1.43% |
| 2016-12-31 | CN¥1.41 Billion ≈ $206.79 Million |
+2.41% |
| 2015-12-31 | CN¥1.38 Billion ≈ $201.93 Million |
+3.90% |
| 2014-12-31 | CN¥1.33 Billion ≈ $194.36 Million |
+4.39% |
| 2013-12-31 | CN¥1.27 Billion ≈ $186.18 Million |
-1.29% |
| 2012-12-31 | CN¥1.29 Billion ≈ $188.61 Million |
+2.23% |
| 2011-12-31 | CN¥1.26 Billion ≈ $184.50 Million |
-2.66% |
| 2010-12-31 | CN¥1.30 Billion ≈ $189.54 Million |
-1.19% |
| 2009-12-31 | CN¥1.31 Billion ≈ $191.82 Million |
-0.58% |
| 2008-12-31 | CN¥1.32 Billion ≈ $192.95 Million |
-3.45% |
| 2007-12-31 | CN¥1.37 Billion ≈ $199.84 Million |
-3.25% |
| 2006-12-31 | CN¥1.41 Billion ≈ $206.56 Million |
-1.56% |
| 2005-12-31 | CN¥1.43 Billion ≈ $209.83 Million |
-0.83% |
| 2004-12-31 | CN¥1.45 Billion ≈ $211.58 Million |
+32.51% |
| 2003-12-31 | CN¥1.09 Billion ≈ $159.67 Million |
+92.03% |
| 2002-12-31 | CN¥568.22 Million ≈ $83.15 Million |
+22.49% |
| 2001-12-31 | CN¥463.89 Million ≈ $67.88 Million |
-8.42% |
| 2000-12-31 | CN¥506.55 Million ≈ $74.12 Million |
+32.58% |
| 1999-12-31 | CN¥382.07 Million ≈ $55.91 Million |
+23.85% |
| 1998-12-31 | CN¥308.50 Million ≈ $45.14 Million |
+19.56% |
| 1997-12-31 | CN¥258.04 Million ≈ $37.76 Million |
-38.38% |
| 1996-12-31 | CN¥418.78 Million ≈ $61.28 Million |
+11.01% |
| 1995-12-31 | CN¥377.23 Million ≈ $55.20 Million |
+0.53% |
| 1994-12-31 | CN¥375.24 Million ≈ $54.91 Million |
+10.73% |
| 1993-12-31 | CN¥338.88 Million ≈ $49.59 Million |
+230.80% |
| 1992-12-31 | CN¥102.44 Million ≈ $14.99 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to China Reform Health Management and Services Group Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17342204400.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥981.31 Million | 69.81% |
| Other Comprehensive Income | CN¥-105.72 Million | -7.52% |
| Other Components | CN¥703.44 Million | 50.05% |
| Total Equity | CN¥1.41 Billion | 100.00% |
China Reform Health Management and Services Group Co Ltd Competitors by Market Cap
The table below lists competitors of China Reform Health Management and Services Group Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Isras Investment Company Ltd
TA:ISRS
|
$1.13 Billion |
|
Hangzhou Greenda Electronic Materials Co Ltd
SHG:603931
|
$1.13 Billion |
|
Hubei Biocause Pharmaceutical
SHE:000627
|
$1.13 Billion |
|
MASTERBRAND INC. DL-001
F:D55
|
$1.13 Billion |
|
Decai Decoration Co Ltd
SHG:605287
|
$1.13 Billion |
|
Kumho Tire
KO:073240
|
$1.13 Billion |
|
Wuhan LinControl Automotive Electronics Co. Ltd. A
SHG:688667
|
$1.13 Billion |
|
Suzhou Huaya Intelligence Technology Co Ltd
SHE:003043
|
$1.13 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in China Reform Health Management and Services Group Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,420,251,225 to 1,405,606,183, a change of -14,645,042 (-1.0%).
- Net loss of 10,375,438 reduced equity.
- Dividend payments of 6,892,677 reduced retained earnings.
- Other comprehensive income decreased equity by 1,315,517.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-10.38 Million | -0.74% |
| Dividends Paid | CN¥6.89 Million | -0.49% |
| Other Comprehensive Income | CN¥-1.32 Million | -0.09% |
| Other Changes | CN¥3.94 Million | +0.28% |
| Total Change | CN¥- | -1.03% |
Book Value vs Market Value Analysis
This analysis compares China Reform Health Management and Services Group Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.51x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 69.43x to 5.51x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1992-12-31 | CN¥0.11 | CN¥7.91 | x |
| 1993-12-31 | CN¥0.38 | CN¥7.91 | x |
| 1994-12-31 | CN¥0.42 | CN¥7.91 | x |
| 1995-12-31 | CN¥0.41 | CN¥7.91 | x |
| 1996-12-31 | CN¥0.46 | CN¥7.91 | x |
| 1997-12-31 | CN¥0.28 | CN¥7.91 | x |
| 1998-12-31 | CN¥0.34 | CN¥7.91 | x |
| 1999-12-31 | CN¥0.42 | CN¥7.91 | x |
| 2000-12-31 | CN¥0.50 | CN¥7.91 | x |
| 2001-12-31 | CN¥0.49 | CN¥7.91 | x |
| 2002-12-31 | CN¥0.59 | CN¥7.91 | x |
| 2003-12-31 | CN¥1.16 | CN¥7.91 | x |
| 2004-12-31 | CN¥1.57 | CN¥7.91 | x |
| 2005-12-31 | CN¥1.58 | CN¥7.91 | x |
| 2006-12-31 | CN¥1.54 | CN¥7.91 | x |
| 2007-12-31 | CN¥1.50 | CN¥7.91 | x |
| 2008-12-31 | CN¥1.43 | CN¥7.91 | x |
| 2009-12-31 | CN¥1.43 | CN¥7.91 | x |
| 2010-12-31 | CN¥1.42 | CN¥7.91 | x |
| 2011-12-31 | CN¥1.37 | CN¥7.91 | x |
| 2012-12-31 | CN¥1.42 | CN¥7.91 | x |
| 2013-12-31 | CN¥1.39 | CN¥7.91 | x |
| 2014-12-31 | CN¥1.46 | CN¥7.91 | x |
| 2015-12-31 | CN¥1.53 | CN¥7.91 | x |
| 2016-12-31 | CN¥1.58 | CN¥7.91 | x |
| 2017-12-31 | CN¥1.57 | CN¥7.91 | x |
| 2018-12-31 | CN¥1.35 | CN¥7.91 | x |
| 2019-12-31 | CN¥1.36 | CN¥7.91 | x |
| 2020-12-31 | CN¥1.07 | CN¥7.91 | x |
| 2021-12-31 | CN¥0.87 | CN¥7.91 | x |
| 2022-12-31 | CN¥0.79 | CN¥7.91 | x |
| 2023-12-31 | CN¥1.56 | CN¥7.91 | x |
| 2024-12-31 | CN¥1.44 | CN¥7.91 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently China Reform Health Management and Services Group Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -0.74%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.91%
- • Asset Turnover: 0.17x
- • Equity Multiplier: 1.47x
- Recent ROE (-0.74%) is below the historical average (0.72%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1992 | 9.03% | 9.92% | 0.66x | 1.39x | CN¥-992.76K |
| 1993 | 8.20% | 37.08% | 0.17x | 1.34x | CN¥-6.09 Million |
| 1994 | 12.30% | 55.82% | 0.12x | 1.79x | CN¥8.63 Million |
| 1995 | -6.37% | -17.90% | 0.23x | 1.58x | CN¥-60.99 Million |
| 1996 | 10.03% | 41.62% | 0.13x | 1.91x | CN¥138.04K |
| 1997 | -63.27% | -91.00% | 0.29x | 2.42x | CN¥-185.87 Million |
| 1998 | 6.69% | 9.19% | 0.30x | 2.41x | CN¥-10.04 Million |
| 1999 | 21.85% | 27.90% | 0.39x | 2.03x | CN¥44.68 Million |
| 2000 | 16.43% | 17.38% | 0.44x | 2.16x | CN¥28.76 Million |
| 2001 | 21.14% | 27.28% | 0.36x | 2.14x | CN¥48.83 Million |
| 2002 | 17.64% | 27.44% | 0.33x | 1.93x | CN¥40.66 Million |
| 2003 | 8.35% | 22.27% | 0.25x | 1.48x | CN¥-17.19 Million |
| 2004 | 25.42% | 95.49% | 0.21x | 1.29x | CN¥217.22 Million |
| 2005 | 2.98% | 16.50% | 0.14x | 1.28x | CN¥-99.78 Million |
| 2006 | -0.26% | -1.90% | 0.11x | 1.27x | CN¥-142.48 Million |
| 2007 | 0.27% | 1.75% | 0.13x | 1.23x | CN¥-130.10 Million |
| 2008 | 0.42% | 1.89% | 0.18x | 1.26x | CN¥-123.72 Million |
| 2009 | 0.64% | 3.18% | 0.16x | 1.26x | CN¥-120.34 Million |
| 2010 | 0.95% | 6.15% | 0.13x | 1.21x | CN¥-115.86 Million |
| 2011 | 1.46% | 11.05% | 0.11x | 1.15x | CN¥-105.29 Million |
| 2012 | 1.89% | 12.49% | 0.13x | 1.16x | CN¥-103.39 Million |
| 2013 | 1.03% | 6.30% | 0.14x | 1.14x | CN¥-112.65 Million |
| 2014 | 1.91% | 12.80% | 0.14x | 1.10x | CN¥-106.05 Million |
| 2015 | 1.68% | 11.90% | 0.13x | 1.08x | CN¥-114.58 Million |
| 2016 | 1.97% | 12.92% | 0.15x | 1.05x | CN¥-114.18 Million |
| 2017 | 1.19% | 16.84% | 0.07x | 1.03x | CN¥-123.83 Million |
| 2018 | -15.48% | -196.65% | 0.07x | 1.06x | CN¥-309.08 Million |
| 2019 | 1.42% | 13.42% | 0.10x | 1.07x | CN¥-104.89 Million |
| 2020 | -25.24% | -116.99% | 0.16x | 1.35x | CN¥-338.72 Million |
| 2021 | -22.38% | -69.63% | 0.21x | 1.52x | CN¥-254.38 Million |
| 2022 | -11.85% | -27.11% | 0.28x | 1.55x | CN¥-155.46 Million |
| 2023 | -5.62% | -24.17% | 0.17x | 1.37x | CN¥-221.82 Million |
| 2024 | -0.74% | -2.91% | 0.17x | 1.47x | CN¥-150.94 Million |
Industry Comparison
This section compares China Reform Health Management and Services Group Co Ltd's net assets metrics with peer companies in the Healthcare Plans industry.
No peer company data available for comparison.
About China Reform Health Management and Services Group Co Ltd
China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. It provides services of medical insurance funds, medical quality and safety, drug and device supervision, and internet health protection. It is also involved in the pharmaceutical and medical business. China Reform Health Management and Services Group Co., Ltd. was formerly known as … Read more